Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

TNF-alpha inhibitors disclosed by Celgene

Jan. 23, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Daiichi and Sumitomo to copromote antiallergic drug in Japan

Jan. 19, 1998

Inhibitors of iNOS developed at Astra

Jan. 16, 1998

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Schering-Plough discovers dual NK1/NK2 antagonists from fungal strain

Jan. 15, 1998

Antiallergic efficacy of dual-action compound demonstrated in preclinical models

Jan. 14, 1998

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...